lipid
Pfizer’s cholesterol-lowering bococizumab shows promise in Phase III trials
April 1, 2016Research and Development, Sales and Marketing Pfizer, bococizumab, lipid, phase 3, phase III, spire, spire-ai
Pfizer (NYSE: PFE) has announced positive top line results from the SPIRE-AI Phase III clinical trial evaluating bococizumab. This protein …
Crestor study has ‘profound implications’ for NICE guidance
November 14, 2008Sales and Marketing Crestor, cv, lipid
AstraZeneca's statin Crestor made national headlines this week when it was shown to dramatically reduce major cardiovascular events. New data …
Pfizer’s torcetrapib results cast doubt on CETP inhibitors
March 30, 2007Research and Development, Sales and Marketing Pfizer, lipid
New data on Pfizer's ill-fated torcetrapib suggest the drug doesn't reduce arterial plaque, casting doubt on other drugs in the …
Kindler sets out new vision for Pfizer
December 1, 2006Sales and Marketing Pfizer, lipid
Pfizer's chief executive Jeffrey Kindler has set out plans for the company to renew itself as an R&D, in-licensing and …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
August 14, 2026
